Skip to main content
    Z

    Zentalis Pharmaceuticals Llc (ZNTL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.49
    -0.11 (-6.88%)

    Market Cap: $157.22M

    Last updated: Nov 17, 2026 at 4:23 PM ET

    Zentalis Pharmaceuticals Llc (ZNTL) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Zentalis Pharmaceuticals Llc (ZNTL) has a latest price of $1.49 on Nov 17, 2026, 78.6% below its 52-week high of $6.95. Its price rose 12.0% over the past 12 months. The month-end price fell 97.6% over the 5 years through Oct 2026, a compound annual decline of 52.4%.

    Price Chart

    From Apr 2020 to Oct 2026, its highest month-end close was $84.06 in Dec 2021 and its lowest $1.16 in Jun 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ZNTL with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ZNTL.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 61.0%, and over 6 months it fell 57.9%. The month-end price fell 88.0% over the 3 years through Oct 2026, a compound annual decline of 50.7%.

    PeriodChange
    1 month-35.2%
    3 months-61.0%
    6 months-57.9%
    12 months+12.0%
    12 months, with dividends+12.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-88.0%-50.7%
    5 years-97.6%-52.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 61.8%, and its weakest was 2024, when it fell 80.0%.

    YearCloseChange
    2026 through Oct 2026$1.96+45.2%
    2025$1.35-55.4%
    2024$3.03-80.0%
    2023$15.15-24.8%
    2022$20.14-76.0%
    2021$84.06+61.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 38.8% below its 50-day average of $2.43 and 56.0% below its 200-day average of $3.39.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.49
    52-week high$6.95-78.6%
    52-week low$1.28+16.4%
    50-day average$2.43-38.8%
    200-day average$3.39-56.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 93.7%.

    MeasureValue
    1-year beta1.82
    Largest fall, 1 year-77.5%
    Largest fall, 3 years-93.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ZNTL

    What is ZNTL's 1-year price change?

    Zentalis Pharmaceuticals Llc's price rose 12.0% over the past 12 months. With dividends included, the 12-month total return was 12.0%.

    What is ZNTL's 5-year price change?

    Zentalis Pharmaceuticals Llc's month-end price fell 97.6% over the 5 years through Oct 2026, a compound annual decline of 52.4%. These figures leave out dividends.

    What is ZNTL's 52-week high and low?

    Zentalis Pharmaceuticals Llc's 52-week high is $6.95 and its 52-week low is $1.28. Its latest price of $1.49 on Nov 17, 2026 is 78.6% below the high.

    What is ZNTL's beta?

    Zentalis Pharmaceuticals Llc's 1-year beta against the S&P 500 is 1.82, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.5%.

    Is the ZNTL chart free?

    Yes. Advanced Charting for ZNTL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.